Daniel Muruve - Arch Biopartners Insider

Co-Founder, Chief Science Officer and Member of Scientific Advisory Board

We currently do not have informatin regarding Daniel Muruve. This executive tanure with Arch Biopartners Inc is not currenlty determined.
  Founder Since 2013      
647-428-7031  http://www.archbiopartners.com

Management Efficiency

The company has return on total asset (ROA) of (85.15) % which means that it has lost $85.15 on every $100 spent on asset. This is way below average.
The company has accumulated 246.87 K in total debt. Arch Biopartners Inc has Current Ratio of 2.71 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Entity Summary

Arch Biopartners, Inc., a biotechnology company, develops solutions and technologies for medical use. Arch Biopartners Inc (FOIFF) is traded on OTC Market in USA. It is located in Arch Biopartners, Inc.Toronto, ON MV M and employs 9 people.

Did you try this?

Run Piotroski F Score Now

Piotroski F Score

Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Hide  View All  NextLaunch Piotroski F Score
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Arch Biopartners Inc to your portfolio

Top Management

Arch Biopartners Inc Leadership Team
Conor Gunne, Director
Richard Rossman, Director
Andrew Bishop, Director, MBA
Claude Allary, Director
Daniel Muruve, Founder
Richard Muruve, CEO, MBA
Patrick Vink, Director
Adrian Haigh, Director

Stock Performance

Arch Biopartners Performance Indicators